tci Part B Insider - 2005 Issue 33

Medication Billing: Ditch 90782, Reach For G0355 For Injections

If your practice provides in-office injections of Avonex for multiple sclerosis patients, you should be claiming G0355 -- rather than 90782 -- for the injection, as of last January.Although some payers still treat Avonex as a "self-injectable" drug, you may charge Medicare carriers for injections provided in the office, as outlined by Medicare transmittal AB-02-072. Avonex is a biologic, not a chemotherapy drug, but G0355 still applies because Avonex administration has similar complexity and resource use as chemotherapy infusions. Tip: Although several carriers have begun to accept G0355 for Avonex injections, to date only Empire Medicare Services has...

To read the full article, sign in and subscribe to tci Part B Insider.


Keep pace with evolving Medicare regulations with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI’s Part B Insider will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4800 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles

This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.